RxSight (RXST) Short-term Investments (2020 - 2026)

RxSight (RXST) has reported Short-term Investments for 7 consecutive years, with $195.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Short-term Investments rose 4.44% year-over-year to $195.4 million; the trailing twelve-month figure through Jun 2026 stood at $195.4 million (up 4.44% YoY), and the FY2025 full-year result was $208.2 million, down 5.6% from the prior year.
• Short-term Investments retreated to $195.4 million in Q2 2026 per RXST's latest filing, from $200.3 million in the prior quarter.
• Across five years, Short-term Investments topped out at $220.5 million in Q4 2024 and bottomed at $92.7 million in Q1 2024.
• Historically, Short-term Investments has averaged $159.8 million across 5 years, with a median of $165.0 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Short-term Investments jumped 423.13% in 2022, then tumbled 35.14% in 2024.
• Over 5 years, Short-term Investments stood at $94.0 million in 2022, then advanced by 25.03% to $117.5 million in 2023, then soared by 87.69% to $220.5 million in 2024, then dropped by 5.6% to $208.2 million in 2025, then retreated by 6.12% to $195.4 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $195.4 million, $200.3 million, and $208.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.